2023 Form 5500 filing — Titan Pharmaceuticals, Inc. Savings & Retirement Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240730173942NAL0032627472001) for Titan Pharmaceuticals, Inc. Savings & Retirement Plan, reported by Titan Pharmaceuticals, Inc. under EIN 94-3171940 and plan number 001. It reports 15 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$2MReported net assets$1,973,576
Participants15
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240730173942NAL0032627472001
Plan sponsor
Titan Pharmaceuticals, Inc.
EIN
94-3171940
Plan number
001
Location
New York, NY
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$2M total assets
Net assets$2MLiabilities
Money in vs. money out
Total income / additions$587.6K
Total expenses$1.7M
Benefits paid / distributions$1.6M
Contributions
Employer$0
Participant$8K
Full reported line items
Total assets (EOY)
$1,973,576
Net assets (EOY)
$1,973,576
Employer contributions
$0
Participant contributions
$8,028
Total income / additions
$587,579
Benefits paid
$1,638,001
Administrative expenses
$14,097
Total expenses
$1,652,098
Net increase / (decrease)
-$1,064,519

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240730173942NAL0032627472001 cover?
It is the 2023 Form 5500 filing for Titan Pharmaceuticals, Inc. Savings & Retirement Plan, reported by Titan Pharmaceuticals, Inc. (EIN 94-3171940).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages